Viewing Study NCT00785668

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:29 PM
Ignite Modification Date: 2026-01-27 @ 9:44 AM
Study NCT ID: NCT00785668
Status: COMPLETED
Last Update Posted: 2008-11-05
First Post: 2008-11-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 1 Safety and Pharmacokinetics Study of AER 001 Administered as a Dry Powder in Asthmatic Subjects
Sponsor: Aerovance, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Asthma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Asthma View
None Allergy View
None Interleukin-4 View
None Interleukin-13 View
None IL-4 View
None IL-13 View
None Pharmacokinetics View
None Safety View
None Tolerability View
None Aerovance View
None dry powder View